Search
for
Sort by
Research 31–60 of 1000+
- Androgen Biosynthesis Inhibitors and Androgen Receptor Antagonists
- hUC-MSC-exosomes deliver Let-7b/7f-5p to dermal papilla cells for a multi-target synergistic treatment of androgenetic alopecia
- Chaperones as thermodynamic sensors
- Androgenic alopecia; the risk–benefit ratio of Finasteride
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss
- Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss
- The Treatment of Hyperandrogenism with Oral Contraceptives
- Targeting receptor–regulator interactions
- Polycystic ovary syndrome: Diagnosis and management
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model
- Polycystic Ovary Syndrome
- Chapter 23. Therapeutic Control of Androgen Action
- The therapeutic use of androgens in women
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Androgen excess is the key element in polycystic ovary syndrome
- Hormonal therapies for acne
- Local synthesis and function of neuro-estrogen and neuro-androgen: impact on the hippocampus-related cognition and neuronal plasticity
- The involvement of androgens in human hair growth
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- The Case of the Elusive Androgen
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review